PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2011; 6(7): e22347.
Published online 2011 July 26. doi:  10.1371/journal.pone.0022347
PMCID: PMC3144223

Functional Hair Cell Mechanotransducer Channels Are Required for Aminoglycoside Ototoxicity

Michael N. Nitabach, Editor

Abstract

Aminoglycosides (AG) are commonly prescribed antibiotics with potent bactericidal activities. One main side effect is permanent sensorineural hearing loss, induced by selective inner ear sensory hair cell death. Much work has focused on AG's initiating cell death processes, however, fewer studies exist defining mechanisms of AG uptake by hair cells. The current study investigated two proposed mechanisms of AG transport in mammalian hair cells: mechanotransducer (MET) channels and endocytosis. To study these two mechanisms, rat cochlear explants were cultured as whole organs in gentamicin-containing media. Two-photon imaging of Texas Red conjugated gentamicin (GTTR) uptake into live hair cells was rapid and selective. Hypocalcemia, which increases the open probability of MET channels, increased AG entry into hair cells. Three blockers of MET channels (curare, quinine, and amiloride) significantly reduced GTTR uptake, whereas the endocytosis inhibitor concanavalin A did not. Dynosore quenched the fluorescence of GTTR and could not be tested. Pharmacologic blockade of MET channels with curare or quinine, but not concanavalin A or dynosore, prevented hair cell loss when challenged with gentamicin for up to 96 hours. Taken together, data indicate that the patency of MET channels mediated AG entry into hair cells and its toxicity. Results suggest that limiting permeation of AGs through MET channel or preventing their entry into endolymph are potential therapeutic targets for preventing hair cell death and hearing loss.

Introduction

Inner ear hair cells are the mechanosensory cells essential for hearing function. As mammalian hair cells do not regenerate, damage or loss of hair cells leads to permanent hearing impairment. One common cause of hair cell death is exposure to aminoglycoside antibiotics [1], [2]. As a result, up to 25% of patients treated with aminoglycosides develop irreversible sensorineural hearing loss [3], [4]. Patients suffering from recurrent or severe infection, such as those with cystic fibrosis, are at particular high risk of such iatrogenic hearing loss [5], [6]. Entry of aminoglycosides into hair cells is necessary to induce cell death [7]. Hair cell death is thought to be mediated by reactive oxygen species [8], [9] and caspase activation [1], [2], [10], [11], although caspase-independent cell death can also occur [12]. Extensive work has characterized the intracellular events occurring after aminoglycosides enter hair cells [3], [8], [13], yet studies examining the mechanism of aminoglycoside entry into hair cells are limited.

In hair cells, aminoglycosides block mechanotransducer (MET) channels [14], [15], [16], [17], ATP receptors [18], Ca-activated K+ channels [19], and nicotinic acetylcholine receptors [20]. The pore size of the narrowest portion of MET channels was estimated at 1.25 nm [21], thus large enough to accommodate the passage of dihydrostreptomycin, an aminoglycoside, whose end-on diameter was estimated at 0.8 nm [22]. Electrophysiological data on mouse cochlear hair cells suggested that dihydrostreptomycin (DHS) was a permeant blocker of the MET channels in vitro [22]. Hypocalcemic conditions, which increase the open probability of MET channels, amplified the blocking efficacy of DHS [17] and increased neomycin's and gentamicin's toxicity in hair cells [23]. In the presence of FM1-43, a permeant blocker of the MET channels, toxicity caused by neomycin, a closely-related aminoglycoside, on mouse hair cells was reduced, suggesting the two drugs compete for entry into hair cells [24], [25].

Alternatively, AGs uptake into hair cells may be via receptor-mediated endocytosis. Endocytic pathways are present in the apical [26], [27], [28] and basolateral membranes of hair cells [29] and could provide a means of AG accumulation. The current study demonstrates that aminoglycoside entry via MET channels is primarily responsible for uptake leading to hair cell death.

Results

Hair cell toxicity caused by aminoglycosides

The first step in assessing AG toxicity and entry mechanisms into sensory hair cells was to develop an in vitro preparation where toxicity could be reproducibly assessed, keeping in mind the limited time course that was available for imaging entry. To this end, an in-depth characterization of hair cell damage as a result of gentamicin treatment was performed. Sensory hair cells along the cochlea were analyzed based on tonotopic location as apical, middle, and basal (Figure 1A). Currents of the MET channels are present in the basal turn of the cochlea at birth and this maturation process continues in culture conditions [30]. By isolating and culturing cochleae from postnatal 4-day-old (P4) pups in control media overnight, we investigated functional 5-day-old hair cells, which have MET channel conductance expressed in a tonotopic manner for outer hair cells, decreasing in a basal-apical gradient. This model system was used to directly investigate the role of mechanotransduction channels in aminoglycoside-induced hair cell death (Figure 1B). AG toxicity is dependent on exposure time, dosage and recovery time. We explored each of these in turn, first treating for 24 hrs and then allowing 0, 24 or 48 hrs of recovery for five doses of gentamicin (Figure 1C). Gentamicin was chosen because of the availability of the fluorescent conjugated compound gentamicin Texas Red (GTTR). The first experiment exposed cultures to doses from 0.1 to 1.0 mM gentamicin for 24 hrs and then allowed recovery for 0, 24 and 48 hrs (Figure 1C). The apical tissue was the least sensitive and basal cells most sensitive to treatment. Disappearance of both parvalbumin 3-labeled cell body and phalloidin-labeled stereocilia bundle of hair cells was used for quantifying hair cell loss. Given that the hair cell body can remain despite stereocilia bundle loss after gentamicin treatment [31], quantification of hair cell body number was used for the remaining experiments. Although there was little immediate cell loss following treatment by 24 hrs, basal cell loss was almost complete at 24 hr recovery while middle regions showed maximal loss for doses greater than 0.1 mM. Apical preparations showed loss of more than 60% only at the highest dose. At 48 hrs of recovery all regions and all doses showed maximal loss. This data indicates that 24 hrs of treatment is too damaging at any dose tested. We then varied the treatment time while maintaining a 48 hr recovery period. The results for the 0.25 mM gentamicin dose is presented in Figure 1D where treatment times varied from 1–24 hrs. From this data we selected the 1 hr treatment time and 48 hr recovery. This treatment gives a tonotopic loss with the base being the most severe (Figure 1D–F). Furthermore the 1 hr treatment can be used for time lapse imaging of uptake properties as well.

Figure 1
Gentamicin causes outer hair cell loss.

Gentamicin uptake into hair cells

The Texas Red-conjugated version of gentamicin (GTTR) allows for live imaging of drug uptake in hair cells [32]. To determine the toxicity profile of GTTR in our in vitro preparation of rat cochlea, the dose-response relationship between outer hair cell survival and GTTR concentration was investigated. Like gentamicin, a dose-dependent outer hair cell loss was noted for GTTR, with the basal turn being the most susceptible (Figure 2A–B). Imaging for NADH signals found that both hair cells and support cells are robust prior to GTTR administration (Figure 2E). In the time frame recorded, uptake of GTTR was detected preferentially in outer and inner hair cells and not in adjacent prox1-labeled supporting cells (Figure 2C). Similar localization was observed for GTTR as for myosin 7a, again supporting selective hair cell uptake. Comparison of GTTR label with staining obtained using a specific antibody for gentamicin (Figure 2F–G) also demonstrates strong colocalization.

Figure 2
Gentamicin selectively enters hair cells.

To determine if entry through MET channels was a significant pathway, organ of Corti cultures were incubated at 37°C with GTTR for 1 hr in the absence and presence of the open channel blocker curare (Figure 3). Figure 3A shows the apical and middle turns where IHC and OHCs were selectively labelled. Some labelling also appears in the remaining portions of Reissner's membrane. Curare, significantly reduces the labelling in hair cells. Figure 3C–D summarizes the uptake as measured in OHCs (C) and IHCs (D). Curare significantly reduced uptake in both cell types. We next further investigated the time course of GTTR uptake under two-photon microscopy.

Figure 3
Open MET channels are required for GTTR entry into hair cells.

Two-photon imaging was used to monitor uptake of GTTR into cultured organ of Corti. The thin focal planes obtained with two-photon microscopy allowed for imaging in the presence of GTTR-containing media, while also limiting photobleaching and phototoxicity. Prior to GTTR application, endogenous fluorescent emission of NADH was observed as an indication of tissue viability (Figure 2E). A lack of NADH signal was interpreted as poor tissue viability and those organs were discarded prior to experimentation. At a normal extracellular calcium concentration (1.2 mM), GTTR was rapidly taken up into the outer hair cells (t = 21.0±0.2 min; Figure 4A). A time lapse video of uptake can be found in Movie S1. This movie illustrates the selectivity of GTTR for hair cells. When applied alone, Texas Red was not detected in either hair cells or supporting cells in the organ of Corti (Figures 4C and H). GTTR (3 µM) demonstrated a steep rate of uptake in the first 30 minutes (Figures 4G–H). Hypocalcemic conditions, which increased the open probability of MET channels [33], [34], raised the rate of GTTR uptake (t = 13.5±0.2 min; Figures 4D and G). Increasing the concentration of GTTR (to 30 µM) also sharply elevated its rate of uptake into hair cells (t = 9.0±0.5 min; Figures 4B and H). No significant GTTR uptake was detected in surrounding supporting cells when GTTR (3 µM) was applied in media containing 1.2 mM [Ca2+ ] (Figure 4A). Lowering extracellular [Ca2+ ] or raising GTTR concentration did not increase GTTR uptake into supporting cells, suggesting that they are not equipped with the mechanisms needed for rapid GTTR uptake present in inner and outer hair cells. GTTR was observed outside hair cells in a delayed fashion (>10 min) both under hypocalcemia (arrowheads in Figure 4B) and high dose GTTR (30 µM) treatment (arrowheads in Figure 4D). This observation is possibly related to leakage of GTTR into the intercellular space as result of damage to the hair cells. Otherwise, the lack of GTTR between cells (particularly OHCs) suggests tight compartmentalization and limited diffusion. Punctate labelling near the basolateral aspects of inner hair cells was occasionally observed when GTTR was administered and was not affected by co-treatment with blockers of MET channels or endocytosis. One possible explanation for these punctate labelling is direct uptake into nerve terminals immediately adjacent to inner hair cells, as gentamicin has been detected in spiral ganglia [35]. If true, the mechanism for this uptake remains to be explored.

Figure 4
Two-photon imaging for GTTR uptake in live cochlear hair cells.

In many cells, the amphipathic styryl dye FM1-43 is internalized via endocytosis [36]. However, its rapid entry into hair cells depends upon open MET channels [24], [25], thus making it a useful compound to compare kinetics with GTTR. When applied at 0.75 µM, its entry into hair cells was rapidly detected in outer hair cells (t = 12.0±0.5 min; Figures 4E and H). Its rate of entry steeply increased when the concentration was increased to 7.5 µM (t = 2.4±0.2 min; Figures 4F and H). The difference in entry rates between FM1-43 and GTTR is likely related to the higher affinity of FM1-43 for the MET channel [17], [25].

To assess the effects of MET channel conductance and endocytosis on the rate of GTTR uptake into hair cells, MET channel blockers representing different chemical classes were used: curare, quinine, and amiloride. GTTR alone entered outer hair cells at a rapid rate (t = 24±1 min), plateauing during the 60 minutes of treatment. For the following experiments, the intensity of fluorescence at 60 minutes (F60) was normalized to this value. Co-treatment with MET channel blockers effectively slowed and reduced uptake of GTTR into hair cells (Figures 5B–C, F). At the concentrations tested, quinine (t = 246.0±4.0 min, 24±7 normalized F60) and curare (t = 83.0±5.0 min, 70±4 normalized F60) were both effective in blocking GTTR uptake. When amiloride was simultaneously applied, an initial phase of GTTR uptake as rapid as that of GTTR alone was observed, followed by a second phase of slower uptake (t1 = 21±1.0 min and t2 = 135.0±7.0 min, 65±5 normalized F60). That GTTR uptake was not completely antagonized is a function of the competitive nature of the block and does not provide evidence for an alternate uptake mechanism.

Figure 5
Kinetics of GTTR uptake with blockers of MET channel or endocytosis.

To more directly test endocytosis as an alternative pathway, concanavalin A and dynosore were tested as nonselective blockers of endocytosis. The rate and final amount of GTTR uptake in outer hair cells were not significantly altered by the co-application of concanavalin A (Figure 5; t = 24±1.0 min; 92±7 normalized F60). The effect of dynosore treatment on GTTR uptake could not be determined because it effectively quenched the fluorescence of GTTR upon application (see Figure S1). Taken together, GTTR entry into hair cells was highly dependent on the patency of MET channels.

To determine the role of mechanotransduction in aminoglycoside-induced hair cell toxicity, the same MET channel blockers were used to limit aminoglycoside toxicity in the following experiments. Cochlear cultures were co-treated with gentamicin and the following MET blockers: quinine, curare, AM1-43, and amiloride. The experimental design was to treat with aminoglycoside alone, antagonist alone, or to co-treat with both compounds. Only experiments where the dose of antagonist did not damage cochlear cultures were included. Administration of AM1-43 (0.25–1.0 µM) proved to be toxic to the sensory epithelium and was therefore excluded from further analysis. When co-administered with gentamicin, both quinine and curare conferred protection against hair cell loss (Figure 6, Figure 7). Hair cell survival was significantly improved by quinine doses of 0.5 mM (92.6% vs. 23.5% in the basal turn; p<0.001) and 1.0 mM (99.6%; p<0.001) and by curare 1.0 mM (99.6%; p<0.001; Figure 6, Figure 7). Although a trend towards improved hair cell survival was observed with co-treatment with amiloride, the degree of protection was variable and did not reach statistical significance (60%; p = 0.4; Figure 6, Figure 7).

Figure 6
Blockers of MET channels, but not endocytosis, protect hair cells from gentamicin toxicity.
Figure 7
Quantitative analysis of outer hair cell survival.

When curare was simultaneously applied with other aminoglycosides, significantly improved hair cell survival was observed (see Figure 7C). For groups treated with streptomycin (hair cell survival improved to 98% from 35%; p<0.01) and dihydrostreptomycin (hair cell survival improved to 102% from 42%; p<0.001). Only a trend towards improved hair cell survival was noted in the neomycin-treated group (hair cell survival: 78% as compared to 55%; p = 0.05). These data suggest that aminoglycosides are similarly entering hair cells via MET channels, the different efficacy likely relates to how well curare competes with the AG or differences in toxicities of the compounds after entry into hair cells. By constructing molecular models of the tested aminoglycosides (streptomycin, dihydrostreptomycin, neomycin, and gentamicin), end-on diameters were estimated to be smaller than the proposed MET channel pore size of 1.25±0.08 nm [21]: 1.04 nm (streptomycin and DHS), 0.98 nm (gentamicin), and 0.96 nm (neomycin).

To determine whether endocytosis played a similar role in aminoglycoside uptake, several inhibitors of this process were also tested. When concanavalin A (Con A; 2.6 µM), a general inhibitor of endocytosis, was co-administered with gentamicin, no significant protection of hair cells was observed (basal turn: 36%; p = 0.2; Figure 6, Figure 7). Inhibition of dynamin by dynosore (80 µM) prevents clathrin-mediated endocytosis [37]. Dynosore did not improve hair cell survival when challenged by gentamicin treatment (basal turn: 24% survival; p = 0.3; Figure 6, Figure 7). Phenylarsine oxide another inhibitor of endocytosis proved to be toxic and so could not be evaluated. Taken together, blockers of MET channels provided significant protection of gentamicin-induced outer hair cell loss, whereas inhibition of endocytosis did not.

To test whether MET channel blockers prevented or delayed hair cell death, cultures were maintained for up to 96 hours post treatment. Figure 8 illustrates these results, demonstrating that hair cell survival was enhanced even after an extended recovery period (100% vs. 32%; p<0.001). It should be noted that changing the experimental paradigm could alter the efficacy of the channel blockers. Given that the aminoglycosides are competing with the channel blockers and the channel blockers are not irreversibly binding to the channel, longer exposure times or higher doses of aminoglycosides would be expected to overwhelm the blocking agents. Competitive blocking of the channel is expected to slow, not prevent entry; therefore, at equilibrium a similar amount of aminoglycoside is expected to have entered the cell, what is different is the time it takes to reach equilibrium. However, this was not observed, as MET channel blockers did effectively prevent hair cell death.

Figure 8
Curare protected hair cells in long-term cultures.

Discussion

A serious side-effect of aminoglycoside antibiotics is irreversible sensorineural hearing loss, which occurs in up to 1 in 4 treated patients [3]. By entering and damaging cochlear hair cells, aminoglycosides cause hair cell death and consequently hearing loss. One possible intervention is to reduce or prevent aminoglycoside uptake into sensory hair cells. The current study was designed to investigate the effects of perturbing two proposed mechanisms of aminoglycoside uptake on hair cell survival.

Similar to previous results using in vitro and in vivo models [38], [39], we found basal outer hair cells to be the most susceptible to damage from gentamicin in vitro. This susceptibility may be explained in part by the higher open probability and single channel conductance of MET channels in hair cells residing in this region [40]. But lower levels of antioxidants among basal hair cells have also been proposed to be responsible for this differential susceptibility [38]. At the early postnatal ages tested, the open probability of the MET channel is the highest in the basal turn, and decreases in a basal-to-apical gradient [30]. All the aminoglycoside antibiotics tested, including GTTR, resulted in a similar damage profile, suggesting a common mechanism of damage and entry into hair cells among these molecules. In support of this notion, we observed loss of apical hair cells with prolonged (24 hr) or high concentration (1.0 mM) of gentamicin treatment, suggesting that increasing the driving force of gentamicin entry into hair cells can overcome a lower open probability of MET channels in apical hair cells [30]. Our observation is in agreement with other damage protocols that yielded nearly complete outer hair cell loss [39], [41].

GTTR uptake into hair cells was enhanced by hypocalcemic conditions, which increases the open probability of the MET channel [34], [42]. This observation is in agreement with the previous findings that hypocalcemia increased the toxicity of aminoglycosides to hair cells [23]. Similarly, treatment paradigms that decrease the open probability of the MET channel, such as hypercalcemia and myosin 7a deficiency, conferred protection to hair cells from aminoglycosides [23], [28]. Alternatively, quinine and curare provided hair cells with protection by blocking the MET channels and thus preventing aminoglycoside entry. Our results are consistent with previous findings that compounds that block aminoglycoside uptake into hair cells are protective [43]. Unlike curare and quinine, amiloride was not as potent at protecting hair cells from gentamicin toxicity. Although it decreased GTTR uptake into hair cells, an initial phase of rapid uptake, comparable to gentamicin alone was observed followed by a slowing of entry, leaving a final GTTR fluorescence comparable to that of curare co-treatment. It is possible that amiloride, which actually binds to the channel and is not an open or permeable blocker, was less effective in limiting the rate of aminoglycoside entry, which may be an important factor for its ultimate toxicity [44]. In light of the extensive body of work demonstrating that aminoglycosides cause a rapid increase in reactive oxygen species in hair cells [8], the rate of aminoglycoside entry into hair cells may be important as the levels of antioxidants in hair cells are limited and may be overwhelmed analogous to any other buffering system [38].

Our results suggest that endocytosis does not play a major role in gentamicin–induce hair cell toxicity. The pharmacology for blocking endocytosis is limited and not very specific given the multiple endocytic mechanisms. It is possible that endocytosis mediates some uptake of aminoglycosides, which can be detected in subcellar compartments such as lysosomes and endoplasmic reticulum [27], [45], [46]. It is also possible that compartmentalization occurs after entry. Another limitation of our current study is that we cannot rule out the possibility that other transport mechanisms might also contribute to AG uptake under other pathologic conditions, such as those by other channels [47]. It would be interesting to elucidate these modes of entry and role of compartmentalized aminoglycosides in future studies.

Although the role of endocytosis may be underestimated, the importance of MET channels is clear. Given the striking protection observed under conditions where the MET channels were largely biased closed, the role of the MET channels may be even more important than presented. Under physiological conditions where calcium is low in the endolymph, the probability of opening of MET channels is much larger than tested here. Also entry of the AGs is driven electrically. Present studies simply used existing membrane potential of the hair cells in culture, rather than increasing driving forces presented by the endocochlear potential and the endolymph solution, or in the case of the GTTR experiments, the warmer temperature. Under more physiological conditions the MET channel open probability is predicted to be closer to 0.3–0.5 as compared to culture condition where it is 0.05–0.1 [42] and the current amplitudes in vivo would be predicted to increase close to an order of magnitude, thus uptake via this mechanism is predicted to be greatly enhanced. The one caveat to this argument is that AGs need to enter the endolymph compartment in order to access the MET channels.

Previous studies have demonstrated that the level of aminoglycoside in the inner ear endolymph does not reach that of plasma, but its clearance time is extremely slow (>30 days) [48]. As steady state levels are a function of both entry and clearance, it is possible that lower endolymph levels reflect high rates of entry into hair cells reducing steady-state values. Alternatively the lower levels in endolymph may explain the lack of immediate hearing loss due to blockage of MET channels prior to hair cell damage. Given that hair cells do not metabolize the AG, accumulation will be cumulative so low levels in endolymph do not reduce the likelihood of entry via MET channels. Studies that examine the kinetics of aminoglycoside entry into the inner ear and sensory hair cells in vivo will help shed light on these possible mechanisms.

Although the molecular composition of the MET channel remains elusive, its pharmacologic and electrophysiologic properties have been characterized [21], [22], [33], [34], [49]. Within the inner ear, only the sensory hair cells exhibit properties of the MET channels. The narrowest portion of the MET channel was estimated at 1.25±0.08 nm [21], thus large enough to accommodate the passage of the aminoglycoside dihydrostreptomycin [22] and the styryl dye FM1-43 [24], [25]. Measurements of the end-on diameters of streptomycin, dihydrostreptomycin, neomycin and gentamicin also found them small enough to pass through these channels. When applied to cochlear hair cells in vitro, both gentamicin and GTTR (Figure 2) are selectively taken up by outer and inner hair cells, but not in adjacent supporting cells. The end-on diameter of GTTR was estimated to be 1.47 nm and thus larger than the reported MET channel pore size (1.25 nm) [21]. Two possible explanations for the observed GTTR uptake into hair cells are first that the MET channel pore size has been underestimated, and second that the MET channel pore temporarily dilates during GTTR entry. In the latter scenario, such a dynamic and reversible dilation has been characterized in other nonselective cation channels [50], [51]. The proposed characteristics are hypothetical and warrant further investigation.

Uptake of gentamicin via receptor-mediated endocytosis was found to occur in proximal renal tubular cells requiring the receptor megalin [52]. While megalin expression is found in the stria vascularis and is notably absent in sensory hair cells [53], whether it similarly binds and transports aminoglycosides in the cochlea is not yet determined. This mechanism of transport in the stria vascularis would be particularly interesting since this is the site where endolymph is produced and aminoglycoside are thought to enter the labyrinth [32]. Inhibiting entry into endolymph may prevent entry into hair cells via MET channels (Figure 8E). Given that MET channels are located atop the stereocilia hair bundles bathed in the scala media, an enclosed fluid compartment with no direct access to a blood supply, aminoglycosides must be transported into endolymph, likely from the stria vascularis [32]. Preventing aminoglycoside entry into the endolymph compartment therefore would be expected to limit toxicity. Alternatively, modifying aminoglycosides to sterically limit their entry into MET channels should also be expected to alleviate ototoxicity. More studies are necessary to validate this potential benefit, including experiments in the whole animal.

In conclusion, hair cell susceptibility to aminoglycoside antibiotics stems from the rapid accumulation of these compounds into the sensory cells because of the novel access via mechanotransducer channels. Preventing access to these channels or permeation of these channels may be viable therapeutic approaches to improving the value of aminoglycosides.

Materials and Methods

Animals and cochlear cultures

Sprague-Dawley rats and C57BL/6 mice were obtained from Charles River laboratory (Cambridge, MA) and Jackson Laboratory (Bar Harbor, ME). All procedures involving animals were approved by the Stanford University committee on animal research (Assurance number A3213-01, Protocol ID 18606).

Tissue cultures

Cochleae were freshly isolated from rat pups. The temporal bones with stria vascularis and modiolus were removed. Whole mount cochleae were then placed onto 10 mm coverslips (Fisher Scientific, Pittsburgh, PA) pre-coated with CellTaK (BD Biosciences, San Jose, CA), and incubated in Dulbecco's Modified Eagle Medium/F12 (Invitrogen, Carlsbad, CA) supplemented with 10% FBS and ampicillin (50 µg/ml; Sigma, St. Louis, MO) for 1–5 days at 37°C in a 5% CO2 atmosphere. Culture media was replenished every 1–2 days. The following drugs were tested: gentamicin, streptomycin, dihydrostreptomycin, neomycin, quinine, amiloride, concanavalin A, dynasore, phenylarsine oxide (all from Sigma), curare (Fisher Scientific), AM1-43 and FM1-43 (Invitrogen). Functional postnatal-day-5 cochleae were specifically chosen for our experiments because most apical and basal hair cells carry transduction currents at this age [30].

Immunohistochemistry and image analyses

Cochlear organs were fixed in 4% PFA for 30 minutes at room temperature (RT), and then immersed in blocking solution [5% goat or donkey serum, 0.1% triton X-100, 1% bovine serum albumin (BSA), and 0.02% sodium azide (NaN3) solution in phosphate buffered solution (PBS) for 1 hour at RT. They were then incubated with primary antibodies in blocking solution overnight at 4°C in a humidified chamber. The following day, tissues were rinsed with PBS three times, and then incubated with secondary antibodies (0.1% triton X-100, 1% BSA, and 0.02% NaN3 solution in PBS) for 1 hour at RT. For labelling for filamentous actin, fluorescently-conjugated phalloidin (Sigma) was applied in 0.1% triton X-100 in PBS for 1 hour. After washing with PBS, tissues were mounted in antifade Fluorescence Mounting Medium (DAKO, Carpinteria, CA) and coverslipped. The following antibodies were used: anti-myosin 7a (1[ratio]1000; Proteus Bioscience, Ramona, CA) [39]; anti-Prox1 (1[ratio]1000; Millipore, Billerica, MA) [54]; anti-parvalbumin 3 (1[ratio]1000) [55]; anti-gentamicin (1[ratio]200; QED Bioscience, San Diego, CA) [56]. The specificity of these antibodies has been previously determined in the referenced studies and/or by their respective suppliers. The respective secondary antibodies were conjugated to either FITC, TRITC or Cy5 (1[ratio]200; Jackson ImmunoResearch, West Grove, PA). Images were acquired using epifluorescent or confocal microscopy (Axioplan 2, Zeiss, Germany) and analyzed with Photoshop CS4 (Adobe Systems, San Jose, CA). The cochlea was divided into apical, middle and basal turns, and separately analyzed. At least 2 representative areas were sampled from each turn for cell quantification. Student t-test was used for statistical comparison. Three-dimensional reconstruction of z-stack images was processed using the Volocity software (v5.3.0; Improvision, Waltham, MA).

Two-photon live imaging

Cochlear organs were cultured overnight as described above, then washed with L-15 (Sigma) before imaging. Gentamicin sulfate (Sigma) and succinimidyl esters of Texas Red dye (Invitrogen) were conjugated to compose GTTR, which was purified before use [32]. GTTR (3–30 µM) and FM1-43 (0.75–7.5 µM) were directly added to cochlear cultures. In experiments testing blockers of MET channels or endocytosis, compounds were concurrently added with GTTR. An Olympus BX-61 (Olympus, Center Valley, PA) coupled to the Prairie Ultima two photon laser scanning microscope with a 100×, 0.9 numerical aperture water immersion objective (Olympus LUMPlan) was used to image the middle turn of the organ of Corti. A 520 nm long-pass dichroic filter (Chroma Technology, Bellows Falls, VT) was used to separate the fluorescence emission into two channels and detected by photomultiplier tubes. Using Prairieview software at 1.4× magnification (Prairie Technologies, Middleton, WI), 60-minute time series were collected at 1-minute intervals. Femtosecond pulses of 900 nm illumination from a tunable Chameleon XR laser (Coherent, Santa Clara, CA) were scanned across the sample using galvanometers, power was regulated with a pockel cell. Red fluorescence originating from GTTR was isolated using a bandpass filter (620/60, Chroma Technology). Prior to adding GTTR, samples were scanned at 740 nm and blue NADH intrinsic fluorescence detected with a bandpass filter (480/30) to confirm the viability of the sample [57] (see Figure 2E). Samples with low NADH signals were discarded.

Data Analysis

To quantify the fluorescence intensity, at least ten individual cells were selected as regions of interest (ROIs) in each T-series. Using Image J software (NIH), the pixels in the ROIs were averaged to determine the total fluorescence intensity. The average background intensity was negligible and therefore was not subtracted from the total fluorescence. The fluorescence for the ten cells was averaged to create a single average fluorescence per T-series. The average of each T-series was normalized to the maximum fluorescence (from experiments using 3 µM GTTR in 1.2 mM calcium) and this normalized average and the standard deviation was plotted as a function of time (OriginLab, Northampton, MA) to determine the average increase in cellular fluorescence over time after GTTR administration (see Figure 4G). In experiments measuring FM1-43 uptake, the average of each T-series was normalized to the maximum fluorescence from experiments using FM1-43 at 0.75 µM (see Figure 4H). Best fit curves were produced using the formula Y = 1−Ae(−x/t), from which the time constants were calculated. Y = 1.2−Ae(−x/t) was used for experiments examining hypocalcemic conditions and Y = 1−(Ae(−x/t1)+Be(x/t2) for experiments examining amiloride.

Chemical models

Drugs were reconstructed using CPK precision Molecular Models (Ealing, South Natick, MA).

Supporting Information

Figure S1

Dynosore quenches fluorescence of GTTR. A. Co-treatment with GTTR (3 µM) and dynosore (80 µM) effectively made GTTR undetectable. B. When GTTR was first added and allowed to enter hair cells and dynosore was later added (15 min), an abrupt plateau of GTTR fluorescence was observed. Error bars = S.D.

(TIF)

Movie S1

Time lapse movie of GTTR uptake. Cochleae harvested from P4 rats were cultured overnight before being treated with GTTR (3 µM). Images were captured every minute for a total of 1 hr under two-photon microscopy.

(MOV)

Acknowledgments

The authors thank Renjie Chai, Taibah Naeem, Vikas Nookala, Bifeng Pan, Anton Peng, Anping Xia, and Robert Strongin (Portland State University) for excellent technical assistance, advice and comments.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was supported by National Institute on Deafness and other Communication Disorders P30 DC010363, University of California, San Francisco Pathway to Discovery Fellowship (to LL), Swiss National Science Foundation PBSKP3_130635/1 (to MH), R01 DC004555 (to PSS), Herbert Silverstein Award and K08 DC011043 (all to AGC), and SPARK (to AJR and AGC), and R01 DC003896 (to AJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Cheng AG, Cunningham LL, Rubel EW. Hair cell death in the avian basilar papilla: characterization of the in vitro model and caspase activation. J Assoc Res Otolaryngol. 2003;4:91–105. [PMC free article] [PubMed]
2. Cunningham LL, Cheng AG, Rubel EW. Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci. 2002;22:8532–8540. [PubMed]
3. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. 2007;15:352–357. [PubMed]
4. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int. 2007;72:931–935. [PubMed]
5. Cheng AG, Johnston PR, Luz J, Uluer A, Fligor B, et al. Sensorineural hearing loss in patients with cystic fibrosis. Otolaryngol Head Neck Surg. 2009;141:86–90. [PubMed]
6. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet. 1993;341:335–339. [PubMed]
7. Hiel H, Schamel A, Erre JP, Hayashida T, Dulon D, et al. Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acid. Hear Res. 1992;57:157–165. [PubMed]
8. Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol. 2000;5:3–22. [PubMed]
9. Hirose K, Westrum LE, Stone JS, Zirpel L, Rubel EW. Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann N Y Acad Sci. 1999;884:389–409. [PubMed]
10. Forge A, Li L. Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res. 2000;139:97–115. [PubMed]
11. Mangiardi DA, McLaughlin-Williamson K, May KE, Messana EP, Mountain DC, et al. Progression of hair cell ejection and molecular markers of apoptosis in the avian cochlea following gentamicin treatment. J Comp Neurol. 2004;475:1–18. [PubMed]
12. Jiang H, Sha SH, Forge A, Schacht J. Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ. 2006;13:20–30. [PMC free article] [PubMed]
13. Cheng AG, Cunningham LL, Rubel EW. Mechanisms of hair cell death and protection. Curr Opin Otolaryngol Head Neck Surg. 2005;13:343–348. [PubMed]
14. Kroese AB, Das A, Hudspeth AJ. Blockage of the transduction channels of hair cells in the bullfrog's sacculus by aminoglycoside antibiotics. Hear Res. 1989;37:203–217. [PubMed]
15. Kros CJ, Rusch A, Richardson GP. Mechano-electrical transducer currents in hair cells of the cultured neonatal mouse cochlea. Proc Biol Sci. 1992;249:185–193. [PubMed]
16. Ohmori H. Mechano-electrical transduction currents in isolated vestibular hair cells of the chick. J Physiol. 1985;359:189–217. [PubMed]
17. Ricci A. Differences in mechano-transducer channel kinetics underlie tonotopic distribution of fast adaptation in auditory hair cells. J Neurophysiol. 2002;87:1738–1748. [PubMed]
18. Lin X, Hume RI, Nuttall AL. Voltage-dependent block by neomycin of the ATP-induced whole cell current of guinea-pig outer hair cells. J Neurophysiol. 1993;70:1593–1605. [PubMed]
19. Dulon D, Sugasawa M, Blanchet C, Erostegui C. Direct measurements of Ca(2+)-activated K+ currents in inner hair cells of the guinea-pig cochlea using photolabile Ca2+ chelators. Pflugers Arch. 1995;430:365–373. [PubMed]
20. Blanchet C, Erostegui C, Sugasawa M, Dulon D. Gentamicin blocks ACh-evoked K+ current in guinea-pig outer hair cells by impairing Ca2+ entry at the cholinergic receptor. J Physiol. 2000;525 Pt 3:641–654. [PubMed]
21. Farris HE, LeBlanc CL, Goswami J, Ricci AJ. Probing the pore of the auditory hair cell mechanotransducer channel in turtle. J Physiol. 2004;558:769–792. [PubMed]
22. Marcotti W, van Netten SM, Kros CJ. The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. J Physiol. 2005;567:505–521. [PubMed]
23. Coffin AB, Reinhart KE, Owens KN, Raible DW, Rubel EW. Extracellular divalent cations modulate aminoglycoside-induced hair cell death in the zebrafish lateral line. Hear Res. 2009;253:42–51. [PubMed]
24. Meyers JR, MacDonald RB, Duggan A, Lenzi D, Standaert DG, et al. Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels. J Neurosci. 2003;23:4054–4065. [PubMed]
25. Gale JE, Marcotti W, Kennedy HJ, Kros CJ, Richardson GP. FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel. J Neurosci. 2001;21:7013–7025. [PubMed]
26. De Groot JC, Huizing EH, Veldman JE. Early ultrastructural effects of gentamicin cochleotoxicity. Acta Otolaryngol. 1991;111:273–280. [PubMed]
27. Hashino E, Shero M. Endocytosis of aminoglycoside antibiotics in sensory hair cells. Brain Res. 1995;704:135–140. [PubMed]
28. Richardson GP, Forge A, Kros CJ, Fleming J, Brown SD, et al. Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells. J Neurosci. 1997;17:9506–9519. [PubMed]
29. Lim DJ. Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. Am J Otolaryngol. 1986;7:73–99. [PubMed]
30. Waguespack J, Salles FT, Kachar B, Ricci AJ. Stepwise morphological and functional maturation of mechanotransduction in rat outer hair cells. J Neurosci. 2007;27:13890–13902. [PubMed]
31. Gale JE, Meyers JR, Periasamy A, Corwin JT. Survival of bundleless hair cells and subsequent bundle replacement in the bullfrog's saccule. J Neurobiol. 2002;50:81–92. [PubMed]
32. Wang Q, Steyger PS. Trafficking of systemic fluorescent gentamicin into the cochlea and hair cells. J Assoc Res Otolaryngol. 2009;10:205–219. [PMC free article] [PubMed]
33. Corey DP, Hudspeth AJ. Ionic basis of the receptor potential in a vertebrate hair cell. Nature. 1979;281:675–677. [PubMed]
34. Crawford AC, Evans MG, Fettiplace R. The actions of calcium on the mechano-electrical transducer current of turtle hair cells. J Physiol. 1991;434:369–398. [PubMed]
35. Roehm P, Hoffer M, Balaban CD. Gentamicin uptake in the chinchilla inner ear. Hear Res. 2007;230:43–52. [PubMed]
36. Betz WJ, Bewick GS, Ridge RM. Intracellular movements of fluorescently labeled synaptic vesicles in frog motor nerve terminals during nerve stimulation. Neuron. 1992;9:805–813. [PubMed]
37. Newton AJ, Kirchhausen T, Murthy VN. Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A. 2006;103:17955–17960. [PubMed]
38. Sha SH, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res. 2001;155:1–8. [PubMed]
39. Oesterle EC, Campbell S, Taylor RR, Forge A, Hume CR. Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear. J Assoc Res Otolaryngol. 2008;9:65–89. [PMC free article] [PubMed]
40. Ricci AJ, Crawford AC, Fettiplace R. Tonotopic variation in the conductance of the hair cell mechanotransducer channel. Neuron. 2003;40:983–990. [PubMed]
41. Hirose K, Sato E. Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea. Hear Res. 2011;272:108–116. [PubMed]
42. Farris HE, Wells GB, Ricci AJ. Steady-state adaptation of mechanotransduction modulates the resting potential of auditory hair cells, providing an assay for endolymph [Ca2+]. J Neurosci. 2006;26:12526–12536. [PMC free article] [PubMed]
43. Ou HC, Cunningham LL, Francis SP, Brandon CS, Simon JA, et al. Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle. J Assoc Res Otolaryngol. 2009;10:191–203. [PMC free article] [PubMed]
44. Rusch A, Kros CJ, Richardson GP. Block by amiloride and its derivatives of mechano-electrical transduction in outer hair cells of mouse cochlear cultures. J Physiol. 1994;474:75–86. [PubMed]
45. Steyger PS, Peters SL, Rehling J, Hordichok A, Dai CF. Uptake of gentamicin by bullfrog saccular hair cells in vitro. J Assoc Res Otolaryngol. 2003;4:565–578. [PMC free article] [PubMed]
46. Myrdal SE, Johnson KC, Steyger PS. Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear Res. 2005;204:156–169. [PMC free article] [PubMed]
47. Karasawa T, Wang Q, Fu Y, Cohen DM, Steyger PS. TRPV4 enhances the cellular uptake of aminoglycoside antibiotics. J Cell Sci. 2008;121:2871–2879. [PMC free article] [PubMed]
48. Tran Ba Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest. 1986;77:1492–1500. [PMC free article] [PubMed]
49. Ricci AJ, Kachar B, Gale J, Van Netten SM. Mechano-electrical transduction: new insights into old ideas. J Membr Biol. 2006;209:71–88. [PMC free article] [PubMed]
50. Banke TG, Chaplan SR, Wickenden AD. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation. Am J Physiol Cell Physiol. 2010;298:C1457–1468. [PubMed]
51. Virginio C, MacKenzie A, North RA, Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol. 1999;519 Pt 2:335–346. [PubMed]
52. Schmitz C, Hilpert J, Jacobsen C, Boensch C, Christensen EI, et al. Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem. 2002;277:618–622. [PubMed]
53. Tauris J, Christensen EI, Nykjaer A, Jacobsen C, Petersen CM, et al. Cubilin and megalin co-localize in the neonatal inner ear. Audiol Neurootol. 2009;14:267–278. [PubMed]
54. Bermingham-McDonogh O, Oesterle EC, Stone JS, Hume CR, Huynh HM, et al. Expression of Prox1 during mouse cochlear development. J Comp Neurol. 2006;496:172–186. [PMC free article] [PubMed]
55. Heller S, Bell AM, Denis CS, Choe Y, Hudspeth AJ. Parvalbumin 3 is an abundant Ca2+ buffer in hair cells. J Assoc Res Otolaryngol. 2002;3:488–498. [PMC free article] [PubMed]
56. Lyford-Pike S, Vogelheim C, Chu E, Della Santina CC, Carey JP. Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration. J Assoc Res Otolaryngol. 2007;8:497–508. [PMC free article] [PubMed]
57. Tiede LM, Rocha-Sanchez SM, Hallworth R, Nichols MG, Beisel K. Determination of hair cell metabolic state in isolated cochlear preparations by two-photon microscopy. J Biomed Opt. 2007;12:021004. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science